LAM
Lynch Asset Management’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.13M | Hold |
46,700
| – | – | 0.4% | 40 |
|
2025
Q1 | $1.18M | Buy |
46,700
+1,200
| +3% | +$30.4K | 0.53% | 37 |
|
2024
Q4 | $1.21M | Buy |
45,500
+600
| +1% | +$15.9K | 0.49% | 37 |
|
2024
Q3 | $1.3M | Buy |
44,900
+400
| +0.9% | +$11.6K | 0.55% | 37 |
|
2024
Q2 | $1.25M | Hold |
44,500
| – | – | 0.53% | 36 |
|
2024
Q1 | $1.23M | Buy |
44,500
+6,200
| +16% | +$172K | 0.58% | 35 |
|
2023
Q4 | $1.1M | Buy |
38,300
+18,300
| +92% | +$527K | 0.63% | 37 |
|
2023
Q3 | $663K | Hold |
20,000
| – | – | 0.44% | 38 |
|
2023
Q2 | $734K | Hold |
20,000
| – | – | 0.47% | 40 |
|
2023
Q1 | $816K | Buy |
20,000
+5,000
| +33% | +$204K | 0.59% | 37 |
|
2022
Q4 | $769K | Hold |
15,000
| – | – | 0.66% | 38 |
|
2022
Q3 | $657K | Hold |
15,000
| – | – | 0.59% | 38 |
|
2022
Q2 | $786K | Hold |
15,000
| – | – | 0.64% | 36 |
|
2022
Q1 | $777K | Hold |
15,000
| – | – | 0.56% | 34 |
|
2021
Q4 | $885K | Buy |
+15,000
| New | +$885K | 0.61% | 35 |
|